However, several other studies have documented greater rates of cognitive decline, bradykinesia, olfactory dysfunction, and less rigidity correlated with GBA mutations [28]
This project was funded in its entirety by Lallemand Health Solutions (LHS) Inc
While animal studies and early clinical reports are promising, its important to note that BPC-157 peptide therapy is not yet FDA-approved for weight loss or any specific medical condition, and large-scale human studies are still needed
Maedi is the parent of two girls
Advanced lipodystrophy reverses fatty liver in mice lacking adipocyte hormone-sensitive lipase
This section is your roadmap for getting to the bottom of your palpitations, putting you in control of your health journey